Literature DB >> 8232288

Characterization of the superinduction of the c-myc proto-oncogene in fibroblasts by benzamide derivatives.

P E Devaraj1, M J Clemens, A P Johnstone.   

Abstract

In mouse fibroblasts stimulated from quiescence into proliferation by serum the induction of expression of the c-myc proto-oncogene is strongly stimulated by 3-methoxybenzamide. Similar superinduction effects are seen with related compounds such as 3-aminobenzamide and the acid analogues, 3-anisic acid and 3-aminobenzoic acid. Whereas the benzamide derivatives are inhibitors of poly(ADP-ribose) polymerase the acid analogues are not, suggesting that inhibition of this enzyme is not the basis for superinduction of the c-myc gene. Analysis of the kinetics of induction of c-myc mRNA indicates that the RNA accumulates more rapidly as well as to a higher level in the presence of serum plus 3-methoxybenzamide than with serum alone. However the stimulation is transient in both cases. Addition of actinomycin D at 30 min or 1 h after serum stimulation shows the c-myc mRNA to be stable at these times, in the presence or absence of 3-methoxybenzamide. Thus the effect of the latter on c-myc mRNA accumulation is likely to be exerted at the level of transcription or RNA processing rather than turnover of the mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232288     DOI: 10.1007/bf00929210

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.

Authors:  A Nepveu; R A Levine; J Campisi; M E Greenberg; E B Ziff; K B Marcu
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

3.  Normalization of multiple RNA samples using an in vitro-synthesized external standard cRNA.

Authors:  A Toscani; D R Soprano; S C Cosenza; T A Owen; K J Soprano
Journal:  Anal Biochem       Date:  1987-09       Impact factor: 3.365

4.  DNA strand breaks and ADP-ribosyl transferase activation during cell differentiation.

Authors:  F Farzaneh; R Zalin; D Brill; S Shall
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

5.  Differential control of proto-oncogene c-myc and c-fos expression in lymphocytes and fibroblasts.

Authors:  R McNerney; D Darling; A Johnstone
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  Induction of B-cell differentiation antigens in interferon- or phorbol ester-treated Daudi cells is impaired by inhibitors of ADP-ribosyltransferase.

Authors:  R Exley; J Gordon; M J Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Rejoining of DNA strand breaks is an early nuclear event during the stimulation of quiescent lymphocytes.

Authors:  A P Johnstone
Journal:  Eur J Biochem       Date:  1984-04-16

8.  Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.

Authors:  M Banasik; H Komura; M Shimoyama; K Ueda
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

9.  Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.

Authors:  C B Thompson; P B Challoner; P E Neiman; M Groudine
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  Some early events in the primary mitogenic stimulation of lymphocytes differ from later interleukin stimulation and other quiescence to growth activation systems.

Authors:  A P Johnstone; D Darling
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

View more
  1 in total

1.  Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster.

Authors:  Yingying Yang; Zhongjing Su; Xuhong Song; Bin Liang; Fanxing Zeng; Xiaolan Chang; Dongyang Huang
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.